The XXIII Congress of the International Society on Thrombosis and Haemostasis and 57th SSC Meeting will be held in Kyoto for 2011.
Showing posts with label Conferences. Show all posts
Showing posts with label Conferences. Show all posts
Wednesday, December 29, 2010
Friday, September 24, 2010
Focused on Latest Clinical and Diagnostic Advances in Coagulation
BEDFORD, Mass., Sept. 23 /PRNewswire/ -- Instrumentation Laboratory (IL), today announced it will host the 2nd IL Asia Pacific Hemostasis Forum on Wednesday, October 13, 2010 at the Grand Hyatt Nusa Dua, in Bali, Indonesia. The event will run from 8:00 am to 12:00 pm, local time. The forum will focus on the latest clinical and diagnostic advances and trends in hemostasis. All healthcare professionals, practicing in the Asia Pacific region are welcome to attend.
Professor Karmel Tambunan, MD, PhD, from the Division of Hematology and Medical Oncology at the University of Indonesia, Jakarta will serve as Scientific Chairman of the Forum. In addition, several prominent experts in the field will present key information and lead discussions during the Forum, including Professor Ismail Elalamy, MD, a Hematologist at the Hopital Tenon, Paris France; Associate Professor Tatsuya Atsumi, MD, PhD, from the Graduate School of Medicine at Hokkaido University, Sapporo, Japan; and, Associate Professor Chris Ward, from the Department of Haemotology and Transfusion Medicine at the Royal North Shore Hospital, Sydney, Australia.
Topics will include new approaches and developments in the diagnosis of Heparin-Induced Thrombocytopenia (HIT), as well as new and emerging markers for Antiphospholipid Syndrome (APS) and associated clinical challenges.
"We are so honored to have some of the leading clinicians from around the world sharing their expertise on HIT and APS management and diagnostics," said Santiago Ramos, Regional Manager for North East Asia. "The Forum will address many of the key issues facing clinicians today and will provide new information to help them deliver the very best patient care."
About HIT
HIT is a severe immune reaction to Heparin that can result in the paradoxical development of a thrombotic event. One of the most common of all adverse drug effects, due to the sheer volume of patients receiving Heparin therapy (over 12 million patients annually in the US alone), it has a significant impact on anticoagulant management in hospitals worldwide. If left untreated, patients with HIT may develop serious sequelae, including pulmonary embolism, myocardial infarction, or death.
Registering to Attend
Through October 1st, 2010, individuals can register to attend this Forum, by contacting Carol Lee, at wbj@werfen-china.com
Professor Karmel Tambunan, MD, PhD, from the Division of Hematology and Medical Oncology at the University of Indonesia, Jakarta will serve as Scientific Chairman of the Forum. In addition, several prominent experts in the field will present key information and lead discussions during the Forum, including Professor Ismail Elalamy, MD, a Hematologist at the Hopital Tenon, Paris France; Associate Professor Tatsuya Atsumi, MD, PhD, from the Graduate School of Medicine at Hokkaido University, Sapporo, Japan; and, Associate Professor Chris Ward, from the Department of Haemotology and Transfusion Medicine at the Royal North Shore Hospital, Sydney, Australia.
Topics will include new approaches and developments in the diagnosis of Heparin-Induced Thrombocytopenia (HIT), as well as new and emerging markers for Antiphospholipid Syndrome (APS) and associated clinical challenges.
"We are so honored to have some of the leading clinicians from around the world sharing their expertise on HIT and APS management and diagnostics," said Santiago Ramos, Regional Manager for North East Asia. "The Forum will address many of the key issues facing clinicians today and will provide new information to help them deliver the very best patient care."
About HIT
HIT is a severe immune reaction to Heparin that can result in the paradoxical development of a thrombotic event. One of the most common of all adverse drug effects, due to the sheer volume of patients receiving Heparin therapy (over 12 million patients annually in the US alone), it has a significant impact on anticoagulant management in hospitals worldwide. If left untreated, patients with HIT may develop serious sequelae, including pulmonary embolism, myocardial infarction, or death.
Registering to Attend
Through October 1st, 2010, individuals can register to attend this Forum, by contacting Carol Lee, at wbj@werfen-china.com
Monday, September 13, 2010
Wednesday, August 18, 2010
International Symposium on Critical Bleeding 2010
International Symposium on Critical Bleeding 2010
September 6-7, 2010 Copenhagen Denmark
Main sessions:
Critical bleeding – overview of concepts
Coagulopathy of Critical Bleeding
Coagulopathy of Trauma - a new entity or an old tale?
Monitoring of haemostasis
Blood products and critical bleeding – what is the evidence?
Case discussions
Alternatives to Blood transfusion
Resuscitation strategies for massive haemorrhage – how I do it
Surgeons and critical bleeding – State of the Art
Antithrombotics and critical bleeding
September 6-7, 2010 Copenhagen Denmark
Main sessions:
Critical bleeding – overview of concepts
Coagulopathy of Critical Bleeding
Coagulopathy of Trauma - a new entity or an old tale?
Monitoring of haemostasis
Blood products and critical bleeding – what is the evidence?
Case discussions
Alternatives to Blood transfusion
Resuscitation strategies for massive haemorrhage – how I do it
Surgeons and critical bleeding – State of the Art
Antithrombotics and critical bleeding
Website HERE
Tuesday, August 17, 2010
Call for Abstracts: 4th International Symposium on Women’s Health Issues in Thrombosis and Haemostasis
Call for Abstracts: 4th International Symposium on Women’s Health Issues in Thrombosis and Haemostasis
February 4-6, 2011 Berlin, Germany
Participants are requested to submit an abstract to the secretariat no later than October 5, 2010 together with the registration form and fees. Authors will be notified regarding abstract acceptance. Accepted abstracts will be presented during a poster session. Abstracts selected by the Scientific Committee will be presented as short Oral Communications during the symposia. All accepted abstracts will be printed in the Book of Abstracts that will be distributed at the Symposium.
Secretariat and Symposium Organizers
Palex Tours Ltd. Israel
59 Ha'atzmaut Road, PO Box 33018, Haifa 33033, Israel
Tel: +972 - 4666 - 0510/11; Fax: +972 - 4852 - 2491
E-mail: whith2011@palex.co.il
Website: www.palexconventions.co.il/whith2011
February 4-6, 2011 Berlin, Germany
Participants are requested to submit an abstract to the secretariat no later than October 5, 2010 together with the registration form and fees. Authors will be notified regarding abstract acceptance. Accepted abstracts will be presented during a poster session. Abstracts selected by the Scientific Committee will be presented as short Oral Communications during the symposia. All accepted abstracts will be printed in the Book of Abstracts that will be distributed at the Symposium.
Secretariat and Symposium Organizers
Palex Tours Ltd. Israel
59 Ha'atzmaut Road, PO Box 33018, Haifa 33033, Israel
Tel: +972 - 4666 - 0510/11; Fax: +972 - 4852 - 2491
E-mail: whith2011@palex.co.il
Website: www.palexconventions.co.il/whith2011
Subscribe to:
Posts (Atom)